In BC patients, MGPT can identify PVs in genes whose association with BC risk is debated, such as mismatch repair (MMR) genes (i.e., MLH1, MSH2, MSH6, and PMS2) responsible for Lynch syndrome (LS). This evidence concerns the gene MSH2 and breast cancer.